|
ORKA Oruka Therapeutics Inc 907654 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-31,820,000.00 |
| Balance Sheet |
|
Current Assets
|
$395,249,000.00 |
|
Assets
|
$504,480,000.00 |
|
Current Liabilities
|
$16,633,000.00 |
|
Liabilities
|
$17,760,000.00 |
|
Equity
|
$486,720,000.00 |
|
Shares Out
|
50167623.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-23,578,000.00 |
|
Investing Cash Flow
|
$-14,437,000.00 |
| Market Analysis |
Market Cap
|
$4,909,403,586.78 |
|
Price
|
$93.84 |
|
BVPS
|
9.70 |
|
PB
|
10.09 |
|
EPS
|
-0.46 |
|
FCF
|
$-23,651,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:19 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:14 |
|
| Apr |
May |
Jun |
| 2026-03-12 |
-0.45 |
|
|
2026-05-13 |
-0.48 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.46 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-0.55 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ORKA documents filed with the SEC.
ORKA Filings
Clear
